Organigram Global (OGI) Common Equity (2018 - 2025)

Organigram Global (OGI) has reported Common Equity for 8 consecutive years, with $253.7 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Common Equity rose 13.1% year-over-year to $253.7 million in Q3 2025; TTM through Sep 2025 was $253.7 million, a 13.1% increase from a year earlier, with the FY2025 full-year figure at $249.8 million, up 11.04% from the prior year.
• Common Equity was $253.7 million for Q3 2025 at Organigram Global, up from $224.3 million in the prior quarter.
• Over five years, Common Equity peaked at $734.3 million in Q4 2021 and troughed at $202.6 million in Q3 2023.
• A 5-year average of $399.0 million and a median of $326.6 million in 2021 frame the typical range for Common Equity.
• The widest YoY moves for Common Equity: up 130.45% in 2021, down 29.32% in 2021.
• Over 5 years, Common Equity stood at $734.3 million in 2021, then sank by 46.28% to $394.5 million in 2022, then slumped by 48.64% to $202.6 million in 2023, then gained by 10.71% to $224.3 million in 2024, then increased by 13.1% to $253.7 million in 2025.
• The last three Common Equity figures came in at $253.7 million (Q3 2025), $224.3 million (Q3 2024), and $202.6 million (Q3 2023), per Business Quant data.